AIM-listed Verici Dx, a developer of advanced clinical diagnostics for organ transplant, has concluded a share placement of 69,111,111 shares at 9.0 pence per share to raise gross proceeds of approximately £6.22m…
UK: Verici Dx raises £6.22m from placement and opens retail offering
…
…






